- China Pacific’s preliminary net income for the fiscal year is expected to increase by approximately 55% to 70%.
- The preliminary net income is projected to be between 42.2 billion yuan and 46.3 billion yuan.
- The estimated net income stands at 44.07 billion yuan.
- The preliminary Earnings Per Share (EPS) is reported to be 2.83 yuan.
- China Pacific has received 19 buy recommendations.
- The company has 5 hold recommendations and no sell recommendations from analysts.
A look at China Pacific Insurance (Group) Co., Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China Pacific Insurance (Group) Co. is receiving high marks in key areas according to Smartkarma Smart Scores. With a top score of 5 in both Value and Dividend categories, the company is seen as offering good value to investors and providing attractive dividends. While Growth is rated slightly lower at 4, China Pacific Insurance (Group) Co. still shows promising potential for expansion. However, Resilience and Momentum scores of 3 and 2 indicate some challenges the company may face in terms of stability and market momentum.
Overall, as an integrated insurance services provider with a focus on life and property insurance products, China Pacific Insurance (Group) Co. is positioned well for the long term. Investors may find the company appealing for its strong value proposition and consistent dividend payouts, though attention should be paid to its growth prospects and market resilience. The company’s performance indicators suggest a mix of opportunities and risks that investors should consider carefully.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
